DHA SBIR SEQUENTIAL MEDICAL RESEARCH AND DEVELOPMENT PHASE II CONTRACT TITLED: AGITUBE (NOW CLR),"FURTHER S…
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- HT942524C0010
- Contractor
- INNOVITAL SYSTEMS INC
- Awarding agency
- Department of Defense
- Sub-agency / office
- Defense Health Agency
- Award amount
- $1,300,000
- Period of performance
- Jan 5, 2024 – May 4, 2027
- NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- PSC AN12
- Place of performance
- BELTSVILLE, MD, 207051000, USA
- Competition
- FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES · Set-aside: SMALL BUSINESS SET ASIDE - TOTAL · 4 offers
- Pricing
- FIRM FIXED PRICE
- Financial breakdown
- Current value $1,300,000 · Obligated $1,300,000 · Potential value $1,300,000 · Latest action obligation $0
Public award description
DHA SBIR SEQUENTIAL MEDICAL RESEARCH AND DEVELOPMENT PHASE II CONTRACT TITLED: AGITUBE (NOW CLR),"FURTHER STUDIES TO REFINE DEVICE USE FOR THE MANAGEMENT OF HEMOTHORAX AND OTHER PLEURAL COLLECTIONS" PLEASE NOTE CLR IS NOT AN ABBREVIATION.
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.